National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Dictionary of Cancer Terms
Send to Printer
CP-358,774

 A drug used to treat certain types of non-small cell lung cancer. It is also used together with gemcitabine to treat pancreatic cancer and is being studied in the treatment of other types of cancer. CP-358,774 is a type of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor. Also called erlotinib, erlotinib hydrochloride, OSI-774, and Tarceva.

Previous Definitions:counseling, COX inhibitor, COX-2, COX-2 inhibitor, Cozaar
Next Definitions:CP-547,632, CP-609,754, CP-724,714, CP4071, CpG 7909